[Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
Wien Klin Wochenschr, 1977/11/25;89(22):741-8.
Dostal V, Fanta D, Reiss-Gutfreund RJ
PMID: 201107
Impact factor: 2.275
Abstract
The epidemiology and clinical features of diseases caused by the herpes simplex virus, are reviewed and recent results are discussed which give an insight into the complex mechanism of primary and chronic, recurrent HSV-1 infections. Immunological reactions in HSV infection and data concerning the oncogenic potential of HSV-1 and -2 are dealt with. Furthermore, current therapeutic possibilities are outlined.
MeSH terms
Amantadine; Animals; Antibody Formation; Antigen-Antibody Complex; BCG Vaccine; Cell Transformation, Neoplastic; Complement C3; Cytarabine; DNA, Viral; Female; Ganglia; Genital Diseases, Female; Genital Diseases, Male; Haplorhini; Herpes Labialis; Herpes Simplex; Herpesvirus 4, Human; Humans; Idoxuridine; Immunity, Cellular; Levamisole; Male; Proflavine; Prostatic Neoplasms; Rabbits; Uterine Cervical Neoplasms; Vidarabine; Viral Vaccines
More resources
EndNote: Download